Advertisement

Loading...

Fresenius SE & Co. KGaA

FSNUYPNK
Healthcare
Medical - Care Facilities
$12.89
$0.11(0.86%)
U.S. Market is Open • 10:12

Fresenius SE & Co. KGaA Fundamental Analysis

Fresenius SE & Co. KGaA (FSNUY) shows weak financial fundamentals with a PE ratio of 79.96, profit margin of 5.52%, and ROE of 6.68%. The company generates $22.8B in annual revenue with weak year-over-year growth of -2.09%.

Key Strengths

No significant strengths identified.

Areas of Concern

ROE6.68%
Operating Margin9.81%
Cash Position1.36%
PEG Ratio9.23
We analyze FSNUY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 29.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
29.3/100

We analyze FSNUY's fundamental strength across five key dimensions:

Efficiency Score

Weak

FSNUY struggles to generate sufficient returns from assets.

ROA > 10%
3.04%

Valuation Score

Weak

FSNUY trades at a premium to fair value.

PE < 25
79.96
PEG Ratio < 2
9.23

Growth Score

Weak

FSNUY faces weak or negative growth trends.

Revenue Growth > 5%
-2.09%
EPS Growth > 10%
1.80%

Financial Health Score

Excellent

FSNUY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.62
Current Ratio > 1
1.32

Profitability Score

Weak

FSNUY struggles to sustain strong margins.

ROE > 15%
6.68%
Net Margin ≥ 15%
5.52%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is FSNUY Expensive or Cheap?

P/E Ratio

FSNUY trades at 79.96 times earnings. This suggests a premium valuation.

79.96

PEG Ratio

When adjusting for growth, FSNUY's PEG of 9.23 indicates potential overvaluation.

9.23

Price to Book

The market values Fresenius SE & Co. KGaA at 5.28 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.28

EV/EBITDA

Enterprise value stands at 26.73 times EBITDA. This signals the market has high growth expectations.

26.73

How Well Does FSNUY Make Money?

Net Profit Margin

For every $100 in sales, Fresenius SE & Co. KGaA keeps $5.52 as profit after all expenses.

5.52%

Operating Margin

Core operations generate 9.81 in profit for every $100 in revenue, before interest and taxes.

9.81%

ROE

Management delivers $6.68 in profit for every $100 of shareholder equity.

6.68%

ROA

Fresenius SE & Co. KGaA generates $3.04 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.04%

Following the Money - Real Cash Generation

Operating Cash Flow

Fresenius SE & Co. KGaA produces operating cash flow of $2.52B, showing steady but balanced cash generation.

$2.52B

Free Cash Flow

Fresenius SE & Co. KGaA produces free cash flow of $1.13B, offering steady but limited capital for shareholder returns and expansion.

$1.13B

FCF Per Share

Each share generates $0.13 in free cash annually.

$0.13

FCF Yield

FSNUY converts 1.13% of its market value into free cash.

1.13%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

79.96

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

9.23

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.28

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.42

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.62

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.32

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.07

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.07

vs 25 benchmark

How FSNUY Stacks Against Its Sector Peers

MetricFSNUY ValueSector AveragePerformance
P/E Ratio79.9627.91 Worse (Expensive)
ROE6.68%687.00% Weak
Net Margin5.52%-45285.00% (disorted) Weak
Debt/Equity0.620.33 Weak (High Leverage)
Current Ratio1.322795.76 Neutral
ROA3.04%-13557.00% (disorted) Weak

FSNUY outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Fresenius SE & Co. KGaA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-39.04%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-75.27%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-43.25%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ